Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Frontiers in Medicine|August 11, 2015
Exosomic microRNAs in the Tumor MicroenvironmentPaolo Neviani, Muller FabbriCurrent Hematologic Malignancy Reports|January 11, 2014
Genetic events other than BCR-ABL1Paolo NevianiCancer Research|December 14, 2018
Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape MechanismsPaolo Neviani, Petra M Wise, Mariam Murtadha, et al.International Journal of Molecular Sciences|December 24, 2021
MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung CancerFrancesca Fanini, Erika Bandini, Meropi Plousiou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2014
SETting OP449 into the PP2A-activating drug familyPaolo Neviani, Danilo PerrottiClinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2007
From mRNA metabolism to cancer therapy: chronic myelogenous leukemia shows the wayDanilo Perrotti, Paolo NevianiThe Lancet. Oncology|May 4, 2013
Protein phosphatase 2A: a target for anticancer therapyDanilo Perrotti, Paolo NevianiCurrent Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
MicroRNAs and cancer epigeneticsMuller FabbriCancer Research|November 2, 2019
Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach?Muller FabbriPhilosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 22, 2017
MicroRNAs and miRceptors: a new mechanism of action for intercellular communicationMuller FabbriPageof 15